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ABSTRACT
The health needs of those living in resource-limited settings are a vastly over-
looked and understudied area in the intersection of machine learning (ML) and
health care. While the use of ML in health care is more recently popularized over
the last few years from the advancement of deep learning, low-and-middle income
countries (LMICs) have already been undergoing a digital transformation of their
own in health care over the last decade, leapfrogging milestones due to the adop-
tion of mobile health (mHealth). With the introduction of new technologies, it is
common to start afresh with a top-down approach, and implement these technolo-
gies in isolation, leading to lack of use and a waste of resources. In this paper,
we outline the necessary considerations both from the perspective of current gaps
in research, as well as from the lived experiences of health care professionals in
resource-limited settings. We also outline briefly several key components of suc-
cessful implementation and deployment of technologies within health systems in
LMICs, including technical and cultural considerations in the development pro-
cess relevant to the building of machine learning solutions. We then draw on
these experiences to address where key opportunities for impact exist in resource-
limited settings, and where AI/ML can provide the most benefit.
1 INTRODUCTION
Achieving the 2030 Agenda for Sustainable Development Goals (SDGs), especially ones that focus
on the promotion of health and well-being through the reduction of preventable deaths, the spread of
epidemics, and universal access to care, are especially difficult in LMICs due to a lack of resources,
capacity, infrastructure, and affordable medicines and treatment (Vinuesa et al., 2020). Here, ma-
chine learning and related AI technologies have been broadly identified as a potential tool for ad-
dressing the unmet health needs for vulnerable and marginalized populations in LMICs (Wahl et al.,
2018).
While early research success has shown promise of clinical relevance of these systems, there exists
still a great number of challenges for the meaningful development and deployment of AI in the field
of health care. A lack of prospective and clinical validation studies to understand the added benefit
for patients is still lacking (Topol, 2019), and the privacy and security of individually identifiable
health data that is used for training and testing of such algorithms are still unresolved concerns in
the wake of anonymized data that can be readily identified (Hejblum et al., 2019).
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1.1 COMPLEXITIES IN CAPACITY IN THE LMIC CONTEXT
However, the LMIC context adds additional layers of complexity in regards to the integration of
AI/ML solutions within health care. For example, a large proportion of deep learning and com-
puter vision research is motivated by the need to address the shortage of experts who can interpret
medical imaging (Rajpurkar et al., 2017) or that can shorten the gap between doctors at different
levels or between hospitals (Rajpurkar et al., 2017), (Li et al., 2019). These frameworks necessarily
lead to experiments that focus primarily on reporting metrics such as area under the curve (AUC)
in order to measure accuracy and predictive validity, which may not necessarily be indicative of
clinical outcomes (Topol, 2019). Yet, such narratives of clinicians being beat by AI-systems con-
tinue to dominate mainstream headlines (Hateley, 2017). These narratives have been pushed back
against by current scholarship, as Topol (2019) lays out, given that the goal instead should be of
synergy between the clinician and the AI system. More recent work has shown that these human-
machine partnerships perform much better than either agent on its own, as demonstrated by a recent
study recruiting 13 radiologists to work together with an AI-mediated platform for chest radiograph
diagnosis (Patel et al., 2019).
Where does this leave resource-poor health systems? On the one hand, machine learning aimed at
replacing clinicians or to fill gaps where expertise lacks does not align with current demographic
trends within LMICs, and in fact aligns more with high income countries instead. More than 40
countries experience shrinking working-age populations, defined as ages 15-64 years of age, while
nearly 80 of counties within the United States specifically lost working-age adults between 2007 and
2017, with further losses projected in the coming years (Hart, 2019). Meanwhile, African nations
are collectively projected to eclipse the workforce of Asia by the end of the 21st century, with a shift
towards youth ready for employment (Tanzi & Lu, 2019). The use of ML to therefore compensate
for a lack of expertise, seems to have little justification in the context of a growing workforce that
can indeed fill those gaps themselves.
Conversely, machine learning tools and algorithms to be used in tandem with expert physicians does
not grapple with the general resource constraints present in LMICs. Not only is it costly and infeasi-
ble to recruit multiple experts to work in alongside AI systems, but the infrastructure of AI systems
themselves can become quite expensive to procure (Bresnick, 2018). A study conducted to assess the
cost of validation and integration of a chronic kidney disease analytics application, for example, was
estimated to cost nearly $220,000 for a single hospital system in the United States (Sendak et al.,
2017). This necessarily prices out health systems in the developing world from implementing these
costly systems. Moreover, pricing models that are distributed as partnerships where a hospital gets
access to the algorithms in exchange for the provision of labeled data do not apply to LMICs. Pa-
tients crossover hospitals based on where they get sick, and the distribution of specialist hospitals
would mean a partnership with such hospital is inaccessible to people from all over the country who
sort service at a specific point in time. These specialist hospitals remain in the large cities, hence
such incentives can exacerbate access to equitable healthcare.
1.2 FURTHER CONSIDERATIONS FROM AN LMIC PERSPECTIVE
Early implementations of digital health technologies traditionally involved a hybrid of paper, mobile
and computer based tools. This is because patients kept a complete record of their health system,
and these records would not be available across institutions. Moreover, poor infrastructure meant
that backups could fail (before adoption of cloud technologies), and electricity could be unavailable
for weeks. Therefore, redundancies became critical in order to minimize interruptions in patient
care. In one specific case, at one of the institutions in Western Kenya, paper and electronic records
were duplicated for years, resulting in a large cost of paper and increased burden to providers who
would need to deal with duplicate data entries. This would inherently result in incomplete records,
specifically due to the isolated and disruptive nature of the EMR/mHealth implementation. A fur-
ther example of this, a given female patient with HIV would be enrolled in the EMR system, and
after pregnancy, would be referred to the antenatal clinic, but after delivery would resume care in
the corresponding Adult HIV clinic while her child would be referred to the another clinic. With
fragmented implementations of health systems, data simply could not be captured by both clinics.
It is precisely these challenges in such workflows that exist given resource-limited contexts, and it
is exactly the challengers that ML developers must be cognizant of, in regards to where gaps may
arise.
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Further, mobile devices are used for many daily activities including healthcare and finance, and early
systems explored web applications, SMS and Interactive voice response systems (IVR). Their suc-
cess has historically been dependent on cost. IVR systems would require memorization of multiple
codes to get to the desired options, while the cost of calls and SMS would be prohibitive. Today,
there are texting applications like WhatsApp that are used for communication, especially in groups.
These technologies will more than likely be incorporated into the ML based solutions given, how-
ever these platforms will inherently have different, and often unaligned, incentives. When Facebook
groups were encouraged for use for the purposes of health education with countries such as Bhutan,
where Facebook would be used to establish a virtual consulting and referral system, misinforma-
tion would not have been a primary concern. However, this is an example that today would be much
more difficult in the era of misinformation, that has for example bolstered the voices of anti-vaxxers.
We posit the notion that delivering health results through these platforms can be harmful, since in-
centives do not always align in the delivery of health information. This is exemplified by studying
the patterns of mobile ownership, whereby the head of the household can own the phone, and hence
when these phones are used for patient care or delivery of critical information then differential pri-
vacy is inadequate since privacy is more than a technical challenge.
Finally, lack of consensus on standards and guidelines presents a conundrum when developing
ML/AI tools for global health. For example, caring for HIV patients in mid-1990’s and early 2000s,
at the peak of the HIV/AIDS crisis, gave way to the criteria for care providers initiating antiretroviral
(ARV) treatment would be a white-blood cell count with a minimum of 200 cells. The reasoning
at the time was inextricably linked to limited resources, and hence a decision was made to treat the
sickest patients as a priority. As funding and an abundance in resources increased, the minimum
count criteria was raised to 350, with a clear directive to initiate ARV treatment as early as possible.
This contextual information is not frequently captured, and as far as the development of ML tools
for LMICs is concerned, can cause harm when such guidelines are implemented and deployed at
scale. This means that the LMICs are also not uniform, therefore requiring the localization of theses
technologies in order to confer power to the communities it intends to serve.
Despite these challenges, several examples of successful and important technology-driven solutions
deployed in resource-limited health care systems exist that can serve as a practical guide for the
development of ML solutions in LMICs. We highlight and provide a broad analysis of such systems
to draw out potential best practices, that can inform critical targets in the global health landscape,
and that can provide opportunities for machine learning to have meaningful impact for patients in
developing countries.
2 CASE ANALYSIS OF SUCCESSFUL IMPLEMENTATIONS
While both Wahl et al. (2018) and Vinuesa et al. (2020) highlight examples of ML systems that
promise potential benefit to patient health in LMICs specifically within the context of the Millen-
nium Development Goals (MDGs) and SDG 3, none provide critical insight into how these models
are integrated, as all are model validation studies. We instead focus on two non-AI examples that
capture key lessons from their development and deployment, as well as their process of integration
in hospital and health care systems within African nations.
2.1 OPENMRS
The OpenMRS (open source medical record system) software was originally designed with the need
to address the unmet need of HIV patients in mind, but soon adopted a broader vision of creating
a robust and scalable open source system for health care delivery (Sims et al., 2019). Data man-
agement solutions that could offload paper documentation for hospitals, not only in the wake of
a staggering number of individuals living with HIV/AIDS, but also given those living with multi-
drug resistant tuberculosis, were critical for the uninterrupted operations of these health systems.
Over a period of more than a decade, OpenMRS has seen its adoption in hundreds of health fa-
cilities spanning 42 countries including South Africa, Kenya, Rwanda and Lesotho, among others
(Seebregts et al., 2009). Its success not only attributable to its considerably reduced cost, but to the
robust open source community (the OpenMRS Implementers Network) that could be depended on
to provide technical support, analogous to what would normally be provided by a commercial entity
(Seebregts et al., 2009).
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Several key factors have been identified as part of the success and growth of OpenMRS, and as
Sims et al. (2019) describes, the dedication and commitment of involved project members at the out-
set of software construction were critical in developing a robust open source community that soon
followed. Being medical professionals first and technologists second not only allowed for the lived
experiences of those caring for patients in these specific communities to shape the development pro-
cess from the beginning, it strengthened a developer community to come together rapidly given their
similar backgrounds, predicated on the belief that writing code really was saving lives (Sims et al.,
2019). This rapid growth in membership also aided directly in bringing other stakeholders such
as intergovernmental organizations to the table to spur new areas of deployment (Seebregts et al.,
2009).
Of note - that such a large proportion of those contributing to the open source software were medical
professionals and clinicians in some cases, meant that a challenge that presented itself during the
development of OpenMRS was that a gap existed between available personnel and those who were
adequately trained. The average time to train a developer was found to be close to 24 months, at
which it was likely they were already being recruited for higher paying developer roles. Therefore,
successful EMR and mHealth tools evolved to rely on an architecture that was simplified using a
web application (initial attempts of OpenMRS were primarily Java based) with a more stable back
end. This provides a critical lesson for the use of ML tools in similar contexts, as it will be more than
likely that personnel training needs are not just for developers, but for future health care providers
who will likely engage daily with these systems. This is also further evidence that shifting work to
a ML system that operates autonomously without creating adequate integration in the workflow of
health care workers, may only have limited short term gains for diagnosis but experience an overall
reduction in capacity building.
2.2 DHIS2
Another open source web-based implementation that has seen marked success in LMICs over a sus-
tained period of more than two decades has been the District Health Information System (DHIS2),
designed as a health management information system to store and retrieve medical data, but also
census and community data, so as to improve the decision making processes for any given health
system (Karuri et al., 2014). The history of DHIS2 itself is rooted deeply in a vision to combat
health inequity, as the development was originally started by the Health Information System Pro-
gramme (HISP) within South Africa, in an attempt to address the disparities in health care due
to apartheid (Braa & Sahay, 2017). The formal partnership between HISP and the researchers from
the University of Oslo brought together seemingly contrasting worlds, that of anti-apartheid activists
and public health officials, alongside Scandanavian programmers with a rich history of open source
development (Karuri et al., 2014). DHIS2 currently is utilized 67 different countries and countless
more health systems, especially South Africa, Ghana, Uganda, and Rwanda (Braa & Sahay, 2017).
Similarly to OpenMRS, DHIS2 early success could be attributed to the strong open source com-
munity forged through projects that connected developers and communities from a wide-range of
stakeholder groups such as health regulatory agencies, NGOs, and academics early on in the de-
velopment process (Karuri et al., 2014). In addition, the educational component of HISP projects,
specifically in South Africa, not only allowed for the training of thousands of health workers to
be educated in the development and maintenance of the system, but also allowed for the project to
spread to other countries and hospital systems as well (Braa & Sahay, 2017).
3 PRACTICAL RECOMMENDATIONS FOR AI HEALTH SOLUTIONS IN LMICS
Previous reviews of challenges and key lessons for ML deployment in resource-limited settings have
heavily focused on data collection, data labeling, and other aspects of the machine learning pipeline
that allows for better model training and deployment (Weber & Toyama, 2010). These are of course
necessary, and the current bias mitigation strategies of understand the context and use of a data set
prior to the training and validation phase are of critical importance.
However, learning from critical open source software that serves as a backbone for health system
infrastructure such as OpeMRS and DHIS2 provides a deeper understanding into the integration that
relies much less on the specific algorithms and computational tools, and much more on design and
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implementation. This is in fact a closely related, but separate issue to clinical validation of machine
learning models, as this phase happens after the design phase but not before.
In both cases, the development of software tools incorporated the eventual users of the system as
co-designers in a collaborative open source environment, which could effectively be considered a
participatory design approach (Braa & Sahay, 2012). Not only does an open source environment
allow for significant cost reduction in hospital procurement (Sims et al., 2019), and build trust with
the communities they serve, but investing in educational tools and investing in training for care
providers to also become code contributors also addressed capacity building among health care
workers and administrators.
This shifts the critical targets for AI/ML in LMICs for health away from stand-alone systems, such
as perhaps computer vision systems competing against clinicians, and rather towards health infor-
mation infrastructure and technology that focuses on capacity building and empowerment of health
care workers already on the ground.
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